In the context of cancer therapy, endostatin is explored as a potential treatment to inhibit tumor growth. Its ability to prevent the formation of new blood vessels can effectively starve tumors, limiting their ability to expand. Various clinical trials have investigated endostatin's efficacy, either as a standalone treatment or in combination with other therapies such as chemotherapy and radiation. While results have been mixed, ongoing research aims to optimize its application and effectiveness.
